DrugPatentWatch Database Preview
Helsinn Company Profile
What is the competitive landscape for HELSINN, and when can generic versions of HELSINN drugs launch?
HELSINN has five approved drugs.
There are thirty US patents protecting HELSINN drugs.
There are two hundred and fifty-eight patent family members on HELSINN drugs in sixty-seven countries and nineteen supplementary protection certificates in eleven countries.
Summary for Helsinn
| International Patents: | 258 |
| US Patents: | 30 |
| Tradenames: | 3 |
| Ingredients: | 4 |
| NDAs: | 5 |
| Patent Litigation for Helsinn: | See patent lawsuits for Helsinn |
| PTAB Cases with Helsinn as patent owner: | See PTAB cases with Helsinn as patent owner |
Drugs and US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | RX | Yes | Yes | 8,895,586 | ➤ Sign Up | ➤ Sign Up | ||||
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | RX | Yes | Yes | 9,908,907 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | AP | RX | Yes | Yes | 7,947,725*PED | ➤ Sign Up | Y | ➤ Sign Up | ||
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | AP | RX | Yes | Yes | 9,125,905*PED | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Helsinn
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-001 | Jul 25, 2003 | 5,202,333*PED | ➤ Sign Up |
| Helsinn Hlthcare | AKYNZEO | netupitant; palonosetron hydrochloride | CAPSULE;ORAL | 205718-001 | Oct 10, 2014 | 5,202,333 | ➤ Sign Up |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | CAPSULE;ORAL | 022233-001 | Aug 22, 2008 | 5,202,333 | ➤ Sign Up |
| Helsinn Hlthcare | ALOXI | palonosetron hydrochloride | INJECTABLE;INTRAVENOUS | 021372-002 | Feb 29, 2008 | 5,202,333*PED | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Helsinn Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2009120493 | ➤ Sign Up |
| Denmark | 2785706 | ➤ Sign Up |
| Croatia | P20170419 | ➤ Sign Up |
| Portugal | 2722045 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Helsinn Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017000059 | Germany | ➤ Sign Up | PRODUCT NAME: CHLORMETHIN; REGISTRATION NO/DATE: EU/1/16/1171 20170303 |
| 745 | Luxembourg | ➤ Sign Up | PRODUCT NAME: NETUPITANT/PALONOSETRON ET LEURS DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (AKYNZEO); FIRST REGISTRATION: 20150527 |
| 2017 00033 | Denmark | ➤ Sign Up | PRODUCT NAME: CHLORMETHINE, HERUNDER CHLORMETHINE HYDROCHLORIDE; REG. NO/DATE: EU/1/16/1171 20170307 |
| 2015 00044 | Denmark | ➤ Sign Up | PRODUCT NAME: NETUPITANT; REG. NO/DATE: EU/1/15/1001 20150527 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
